Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular signalling networks using SILAC-based phosphoproteomics. Issue 13 (2nd July 2020)

• Record Type: Journal Article
• Authors: Byrne, Dominic P.; Clarke, Christopher J.; Brownridge, Philip J.; Kalyuzhnyy, Anton; Perkins, Simon; Campbell, Amy; Mason, David; Jones, Andrew R.; Eyers, Patrick A.; Eyers, Claire E.
• Is Part Of: Biochemical journal. Volume 477:Issue 13(2020)
• Page Start: 2451
• Page End: 2475
• Publication Date: 2020-07-02
• Subjects: inhibitor -- phosphoproteomics -- PLK4 -- protein kinase -- signalling -- substrate specificity; Biochemistry -- Periodicals; 572
• DOI: 10.1042/BCJ20200309
• Languages: English
• ISSNs: 0264-6021

Abstract

Abstract : Polo-like kinase 4 (PLK4) is the master regulator of centriole duplication in metazoan organisms. Catalytic activity and protein turnover of PLK4 are tightly coupled in human cells, since changes in PLK4 concentration and catalysis have profound effects on centriole duplication and supernumerary centrosomes, which are associated with aneuploidy and cancer. Recently, PLK4 has been targeted with a variety of small molecule kinase inhibitors exemplified by centrinone, which rapidly induces inhibitory effects on PLK4 and leads to on-target centrosome depletion. Despite this, relatively few PLK4 substrates have been identified unequivocally in human cells, and PLK4 signalling outside centriolar networks remains poorly characterised. We report an unbiased mass spectrometry (MS)-based quantitative analysis of cellular protein phosphorylation in stable PLK4-expressing U2OS human cells exposed to centrinone. PLK4 phosphorylation was itself sensitive to brief exposure to the compound, resulting in PLK4 stabilisation. Analysing asynchronous cell populations, we report hundreds of centrinone-regulated cellular phosphoproteins, including centrosomal and cell cycle proteins and a variety of likely 'non-canonical' substrates. Surprisingly, sequence interrogation of ∼300 significantly down-regulated phosphoproteins reveals an extensive network of centrinone-sensitive [Ser/Thr]Pro phosphorylation sequence motifs, which based on our analysis might be either direct or indirect targets of PLK4. In addition, we confirm that NMYC and PTPN12 are PLK4 substrates, both in vitro and in human cells. Our findings suggest that PLK4 catalytic output directly controls the phosphorylation of a diverse set of cellular proteins, including Pro-directed targets that are likely to be important in PLK4-mediated cell signalling.